Mendez Schmidt (clubdancer86)

The results suggest that the probiotic protection may extend beyond just intestinal health and intestinal barrier function.The present experiment aimed to compare toxic effects of dietary organic or inorganic selenium (Se) and to predict of Se intake and tissue Se concentrations in broiler chickens based on feather Se concentrations. A total of four hundred twenty 7-day-old Ross 308 male broiler chicks were allotted to 1 of 7 dietary treatments in a completely randomized design. Each treatment had 6 replicates with 10 birds per replicate. Organic Se (selenium yeast) or inorganic Se (sodium selenite) was added to the basal diet at the levels of 5, 10, or 15 mg/kg Se. All experimental diets were fed to birds on an ad libitum basis for 28 d. Results indicated that a significant interaction (P less then 0.01) was observed between Se sources and inclusion levels for the BW gain and feed intake of broiler chickens with inorganic Se at 15 mg/kg in diets showing a greatest negative effect. Increasing inclusion levels of Se in diets increased (linear, P less then 0.01) plasma concentrations of uric acid. Increasing inclusion levels of Se in diets increased (linear, P less then 0.01) relative liver weight. No significant interactions were observed between Se sources and inclusion levels in diets on hepatic antioxidant capacity. Increasing inclusion levels of Se in diets increased (linear, P less then 0.01) Se concentrations in the liver, breast, and feather. The concentrations of Se in the breast, liver, and feather were greater (P less then 0.05) for organic Se than for inorganic Se in diets. The toxic levels of organic or inorganic Se in broiler diets were near 7 or 9 mg/kg based on the BW gain, respectively. The prediction equations indicate that feather Se concentrations in broiler chickens can be used to predict both daily Se intake and Se concentrations in the liver and breast.Currently, the widely used vaccine against duck Tembusu virus (DTMUV) disease is inactivated vaccine which, however, facing the limits of large inoculation dose, short immunization period, and incomplete effectiveness. Access to efficient adjuvants aiding for DTMUV inactivated vaccine seems to be of critical importance. Interleukin-2 (IL-2) was reported to induce a persistent expansion of effector T cells and could be a promising molecular adjuvant for many kinds of vaccines. In this study, the efficacy of duck interleukin (dIL)-2 as an adjuvant for a DTMUV inactivated vaccine was evaluated. Fifty-five Pekin ducks were divided into 5 groups and intramuscularly administered with 5 batches of vaccines at 42 D (A DTUMV + dIL-2; B 1/2DTUMV + dIL-2; C DTUMV; D 1/2DTUMV and E PBS), respectively, and received the second vaccination 2 wk later. Fifty-six days after immunization, 6 ducks from each group were randomly selected to conduct a challenge protection test. Antibody titers and cytokine responses were detected to assess humoral and cellular immune responses in serum of inoculated ducks by hemagglutination inhibition and ELISA, respectively; virus isolation and RT-PCR method were used in immunity protective test. Our results showed that dIL-2 exerted an enhanced effect on the vaccine while reducing the dose of inoculated antigen highlighting high adjuvanticity of IL-2. The vaccines supplemented with IL-2 induced a higher level of antibodies and higher percentage of inhibition values than inactivated vaccines without IL-2 to a significant extent. The production level of IFN-α, IFN-γ, and IL-6 genes were elevated, enhancing both humoral and cellular responses. Furthermore, it provided higher protection after virus challenge. Therefore, IL-2 can be considered as a potential adjuvant for inactivated vaccine against DTMUV disease.Fowl adenovirus (FAdV) has posed a grave threat to the health of poultry, and the sudden outbreak highlights the importance of the new rapid diagnostic method for the control and prevention of transmission. Hence, in the present study, a